Cystic Fibrosis Weekly Update

Contents:

Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates

Sep 18, 2019 07:00 am | Jose Marques Lopes, PhD

Translate Bio is going to focus on the development of potential therapies to treat pulmonary diseases, including its lead candidate, MRT5005, targeting the underlying cause of cystic fibrosis (CF), the company announced. MRT5005 is designed to restore the levels of working cystic fibrosis transmembrane conductance regulator (CFTR) protein and reverse the effects of any CF-related genetic mutation. The […]
The post Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates appeared first on Cystic Fibrosis News Today.

Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds

Sep 17, 2019 07:00 am | Patricia Inacio, PhD

Prenatal genetic testing for cystic fibrosis (CF) significantly influences how women manage their pregnancies, with positive tests linked to high rates of pregnancy terminations, a systematic review study finds. The study, “Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review,” was published in the journal Genetics in Medicine. […]
The post Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds appeared first on Cystic Fibrosis News Today.

Our Colons Need Your Help

Sep 16, 2019 03:00 pm | Bailey Vincent

This column is about colons. Someone needs to be studying the prevalence of colorectal conundrums in people with CF and correlated diseases, especially those in their late 20s and early 30s. The number of messages I get from friends and strangers about colons is miles long (possible colon pun). They all begin the same way: […]
The post Our Colons Need Your Help appeared first on Cystic Fibrosis News Today.